Maraviroc 150 mg QD plus lopinavir/ritonavir, a NRTI-sparing regimen for HIV-infected naïve patients: 48-weeks final results
Nozza, S, Galli, L, Chiappetta, S, Antinori, A, Tommasi, C, Di Pietro, M, Malnati, M, De Battista, D, Tambussi, G, Lazzarin, AVolume:
15
Journal:
Journal of the International AIDS Society
DOI:
10.7448/IAS.15.6.18232
Date:
November, 2012
File:
PDF, 181 KB
2012